Schedule 13D ownership disclosure

REVIVA PHARMACEUTCLS HLDGS I

Security class unavailable · CUSIP: 76152G100

Event date: 2024-05-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,958,668
Percent of class
6.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-24-022270
Form type
SC 13D/A
Filer
REVIVA PHARMACEUTICALS HOLDINGS, INC.
CIK
CIK 1742927
Filed
May 31, 2024
Reporting period
May 29, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub